JP2022538363A5 - - Google Patents

Info

Publication number
JP2022538363A5
JP2022538363A5 JP2021577993A JP2021577993A JP2022538363A5 JP 2022538363 A5 JP2022538363 A5 JP 2022538363A5 JP 2021577993 A JP2021577993 A JP 2021577993A JP 2021577993 A JP2021577993 A JP 2021577993A JP 2022538363 A5 JP2022538363 A5 JP 2022538363A5
Authority
JP
Japan
Prior art keywords
pyridine
pyrazolo
methyl
trifluoromethyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538363A (ja
JP7606479B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/068574 external-priority patent/WO2021001453A1/en
Publication of JP2022538363A publication Critical patent/JP2022538363A/ja
Publication of JP2022538363A5 publication Critical patent/JP2022538363A5/ja
Application granted granted Critical
Publication of JP7606479B2 publication Critical patent/JP7606479B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577993A 2019-07-04 2020-07-01 エストロゲン関連受容体アルファ（ＥＲＲα）モジュレーター Active JP7606479B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19184515.5 2019-07-04
EP19184515 2019-07-04
PCT/EP2020/068574 WO2021001453A1 (en) 2019-07-04 2020-07-01 ESTROGEN-RELATED RECEPTOR ALPHA (ERRα) MODULATORS

Publications (3)

Publication Number Publication Date
JP2022538363A JP2022538363A (ja) 2022-09-01
JP2022538363A5 true JP2022538363A5 (https=) 2023-07-07
JP7606479B2 JP7606479B2 (ja) 2024-12-25

Family

ID=67180693

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577993A Active JP7606479B2 (ja) 2019-07-04 2020-07-01 エストロゲン関連受容体アルファ（ＥＲＲα）モジュレーター

Country Status (17)

Country Link
US (1) US12527774B2 (https=)
EP (1) EP3994138B1 (https=)
JP (1) JP7606479B2 (https=)
KR (1) KR20220029719A (https=)
CN (1) CN114341135B (https=)
AR (1) AR119348A1 (https=)
AU (1) AU2020298779A1 (https=)
BR (1) BR112021026687A2 (https=)
CO (1) CO2021017619A2 (https=)
ES (1) ES3032908T3 (https=)
IL (1) IL289510B2 (https=)
MA (1) MA56444A (https=)
MX (1) MX2022000165A (https=)
PH (1) PH12021553204A1 (https=)
UA (1) UA129204C2 (https=)
WO (1) WO2021001453A1 (https=)
ZA (1) ZA202200591B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023011456A1 (en) * 2021-08-03 2023-02-09 Beigene, Ltd. Pyrazolopyridinone compounds
EP4486741A4 (en) 2022-03-01 2026-04-08 Insilico Medicine Ip Ltd Diacylglycerol Kinase (DGK) Alpha Inhibitors and Their Uses
WO2023165525A1 (en) * 2022-03-01 2023-09-07 Insilico Medicine Ip Limited Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA016887B1 (ru) * 2007-03-07 2012-08-30 Янссен Фармацевтика Н.В. ЗАМЕЩЁННЫЕ ФЕНОКСИАМИНОТИАЗОЛОНЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ РОДСТВЕННОГО ЭСТРОГЕНОВОМУ РЕЦЕПТОРУ РЕЦЕПТОРА-α
NZ579372A (en) 2007-03-07 2012-02-24 Janssen Pharmaceutica Nv Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
CN103288823B (zh) * 2012-02-23 2015-02-18 华东理工大学 N,n’-芳基取代脲类化合物及其用途
CN104119285B (zh) 2013-04-28 2016-06-29 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
KR101819639B1 (ko) * 2016-06-27 2018-01-17 주식회사 케미메디 신규한 아릴에텐 유도체 및 이를 유효성분으로 함유하는 약제학적 조성물

Similar Documents

Publication Publication Date Title
US10865196B2 (en) Compounds for treatment of cancer
JP2022538363A5 (https=)
JP5529746B2 (ja) 炎症性疾患、心臓血管疾患及び中枢神経系障害を治療するための置換されたベンゾアゾールｐｄｅ４阻害剤
JP2020033357A5 (https=)
JP2021503458A5 (https=)
CA2540541A1 (en) Alkoxy substituted imidazoquinolines
US9029408B2 (en) Compounds for treatment of cancer
CA2651363A1 (en) Triazolopyrazine derivatives useful as anti-cancer agents
RU2004116916A (ru) Производные 5,6-биарил-пиразин-2-амида в качестве антагонистов cb1
JP2008516986A5 (https=)
RU2007119637A (ru) Соединения и композиции в качестве модуляторов hedgehog-пути
RU2014105169A (ru) 2-пиридилзамещенные имидазолы в качестве ингибиторов alk5 и/или alk4
RU2013138834A (ru) N-[3-(5-амино-3,3а,7,7а-тетрагидро-1н-2,4-диокса-6-аза-инден-7-ил)-фенил]-амиды в качестве ингибиторов васе1 и(или) васе2
RU2008141511A (ru) Конденсированные гетероциклические соединения и их применение в качестве модуляторов mglur5
CA3136324A1 (en) Acss2 inhibitors and methods of use thereof
EP2247601B1 (en) Thiazopyrimidinones and uses thereof
JP2018521119A5 (https=)
CA2989722A1 (en) Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy
RU2013127155A (ru) Новые замещенные бициклические ароматические соединения в качестве ингибиторов s-нитрозоглутатион-редуктазы
JP2010502576A5 (https=)
JP2015524483A5 (https=)
US12527774B2 (en) Estrogen-related receptor alpha modulators
RU2006138606A (ru) Ингибиторы киназы
RU2016112164A (ru) КОНФОРМАЦИОННО ОГРАНИЧЕННЫЕ ИНГИБИТОРЫ PI3K И mTOR
HRP20171567T1 (hr) Supstituirani 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizohinolin-4-karboksamidi za antimalarijske terapije